← back to search

Daniel Karl

Precision BioSciences (United States) · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Histone Deacetylase Inhibitors Research, Protease and Inhibitor Mechanisms, and Cancer-related gene regulation.
h-index
18
citations
1,223
works
60
NIH funding
primary concept
email

Recent publications

The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression
Journal of Clinical Investigation 2023cited by 19position: middledoi
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
Cell Reports 2023cited by 17position: middledoi
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
JCI Insight 2021cited by 19position: middledoi
PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2
Nucleic Acids Research 2020cited by 69position: middledoi
Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer
Science Advances 2020cited by 51position: middledoi
TAF1 plays a critical role in AML1-ETO driven leukemogenesis
Nature Communications 2019cited by 54position: middledoi
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Cell Reports 2018cited by 227position: middledoi
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis
Cancer Cell 2018cited by 78position: middledoi
Caspase-3 controls AML1-ETO–driven leukemogenesis via autophagy modulation in a ULK1-dependent manner
Blood 2017cited by 56position: middledoi
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia‐inducible factor 1α
International Journal of Cancer 2012cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Na Man · ShanghaiTech University7 papers (2017–2023)Stephen D. Nimer · University of Miami7 papers (2017–2023)Fan Liu · Jiangnan University6 papers (2017–2021)Concepción Martínez · University of Miami5 papers (2018–2021)Stéphanie Duffort · University of Miami5 papers (2018–2023)Sarah Greenblatt · Genomics Institute of the Novartis Research Foundation4 papers (2017–2019)Ye Xu · Xinjiang Production and Construction Corps4 papers (2018–2021)Pierre-Jacques Hamard · Memorial Sloan Kettering Cancer Center4 papers (2018–2021)Feng‐Chun Yang · The University of Texas at San Antonio Health Science Center3 papers (2017–2021)Glòria Mas Martín · University of Miami3 papers (2019–2023)Jun Sun · University of Miami3 papers (2019–2021)Adnan K. Mookhtiar · Sylvester Comprehensive Cancer Center3 papers (2018–2023)Mingjiang Xu · The University of Texas Health Science Center at San Antonio3 papers (2017–2021)Ramin Shiekhattar · University of Miami2 papers (2019–2023)Lan Wang · South China Agricultural University2 papers (2017–2019)Hidehiro Itonaga · Sylvester Comprehensive Cancer Center2 papers (2021–2023)Francisco Vega · The University of Texas MD Anderson Cancer Center2 papers (2018–2023)María E. Figueroa · University of Miami2 papers (2019–2021)Daniel Bilbao · University of Miami2 papers (2018–2023)Ramiro E. Verdún · University of Miami2 papers (2018–2020)